Correlation of HGAL expression with clinical variables
| Variable . | HGAL expression† . | ||
|---|---|---|---|
| Negative, % . | Positive, % . | Fisher exact P . | |
| Sex | .85 | ||
| Male | 24 | 76 | |
| Female | 27 | 73 | |
| Age, y | .05 | ||
| Less than 45 | 21 | 79 | |
| 45 or more | 39 | 61 | |
| Stage | .70 | ||
| I, II | 24 | 76 | |
| III, IV | 28 | 72 | |
| IPS | .83 | ||
| 2 or below | 26 | 74 | |
| More than 2 | 29 | 71 | |
| Bulky disease | .83 | ||
| No | 27 | 73 | |
| Yes | 24 | 76 | |
| Histology | > .99 | ||
| Nodular sclerosis | 26 | 74 | |
| Other | 25 | 75 | |
| B symptoms* | > .99 | ||
| No | 24 | 76 | |
| Yes | 25 | 75 | |
| No. of involved sites* | .75 | ||
| 1 to 3 | 25 | 75 | |
| More than 3 | 18 | 82 | |
| Variable . | HGAL expression† . | ||
|---|---|---|---|
| Negative, % . | Positive, % . | Fisher exact P . | |
| Sex | .85 | ||
| Male | 24 | 76 | |
| Female | 27 | 73 | |
| Age, y | .05 | ||
| Less than 45 | 21 | 79 | |
| 45 or more | 39 | 61 | |
| Stage | .70 | ||
| I, II | 24 | 76 | |
| III, IV | 28 | 72 | |
| IPS | .83 | ||
| 2 or below | 26 | 74 | |
| More than 2 | 29 | 71 | |
| Bulky disease | .83 | ||
| No | 27 | 73 | |
| Yes | 24 | 76 | |
| Histology | > .99 | ||
| Nodular sclerosis | 26 | 74 | |
| Other | 25 | 75 | |
| B symptoms* | > .99 | ||
| No | 24 | 76 | |
| Yes | 25 | 75 | |
| No. of involved sites* | .75 | ||
| 1 to 3 | 25 | 75 | |
| More than 3 | 18 | 82 | |